Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : KH-001 Besylate
Therapeutic Area : Psychiatry/Psychology
Study Phase : IND Enabling
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : KH-001 Besylate is a unique, proprietary on-demand drug being developed as the first FDA-approved treatment for premature ejaculation, the most common form of male sexual dysfunction.
Product Name : KH-001
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
November 16, 2023
Lead Product(s) : KH-001 Besylate
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : IND Enabling
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
